MedPath

The Utility of Customised Growth Charts for Identifying Macrosomia and the Effect of Intervention

Completed
Conditions
Ultrasound
Obstetric Complication
Fetal Growth Complications
Induction of Labor Affected Fetus / Newborn
Interventions
Procedure: Induction of labour
Registration Number
NCT04536753
Lead Sponsor
Newcastle University
Brief Summary

Best management of suspected large for gestational age (LGA) fetuses is unclear. In some hospitals women with an LGA fetus by customised growth charts are are offered earlier induction. This study aimed to examine scan accuracy for this group and the outcome with intervention.

Detailed Description

This is a retrospective cohort study of pregnant women taken from 3 groups; women with a suspected LGA fetus (LGA), women with diabetes (DM) and a control group of women that underwent induction of labour at or after 40 weeks. Scan accuracy using GROW and WHO charts in the LGA and DM cohorts was assessed using ROC curves and outcomes between the cohorts was compared.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
845
Inclusion Criteria
  • Induced labour of a singleton pregnancy at Northumbria Healthcare Foundation trust resulting in a delivery between 01/01/2018 and 31/12/2018.

Inclusion in the LGA group means that the main indication for induction is recorded as suspected macrosomia.

Inclusion in the Diabetic group means diabetes was pre-existing or arose in pregnancy, diagnosed by oral glucose tolerance testing from 24-30 weeks or by home blood glucose monitoring with standard thresholds as per NICE ng3. Induction had to be undertaken with diabetes as the (co)indication.

Inclusion criteria for the control group was induction of labour at or after 280 days gestation

Exclusion Criteria

Previous caesarean section Multiple pregnancy Fetal concerns pre-induction: abnormal antenatal trace or abnormal doppler flow studies on antenatal ultrasound

  • Cases of induction for suspected LGA are to be excluded if there is a co-indication of obstetric cholestasis, hypertensive disorder or diabetes.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
ControlInduction of labourAll other women induced at or after 280 days of gestation
Suspected large for gestational age (LGA)Induction of labourWomen with pregnancies suspected to be complicated by fetuses weighing more than the 90th centile on customised growth chart and induced for this reason prior to 287 days as the main indication without diabetes.
Women with diabetes (DM)Induction of labourWomen with diabetes in pregnancy induced at between 259 and 266 days if on treatment and 273 days if gestational diabetes managed with diet alone.
Primary Outcome Measures
NameTimeMethod
Mode of deliverythrough study completion, an average of 1 year

Caesarean section and assisted delivery rates

Shoulder dystocia ratethrough study completion, an average of 1 year

Any clinically diagnosed cases of shoulder dystocia where the shoulders did not deliver with routine axial traction on the next contraction after the head was delivered.

Estimated blood lossthrough study completion, an average of 1 year

Blood loss as estimated by the clinical team

Obstetric Anal Sphincter Injurythrough study completion, an average of 1 year

Any tear involving the external anal sphincter and/or rectal mucosa

Admission to special care baby unit (SCBU)through study completion, an average of 1 year

Admission of neonate to neonatal unit from labour ward

Epidural ratethrough study completion, an average of 1 year

Use of epdiural analgesia intrapartum

Birthweightthrough study completion, an average of 1 year

Neonatal weight as taken following delivery

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Benjamin Simpson

🇬🇧

Newcastle Upon Tyne, Tyne And Wear, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath